Meridian Wealth Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-506
Closed -$59.9K 553
2023
Q2
$59.9K Buy
+506
New +$63.1K 0.01% 538

Other funds holding LABU

Meridian Wealth Management's LABU Position: Q3 2023 in Review

Meridian Wealth Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 506 shares — an estimated $59.9K sold.

Meridian Wealth Management first reported a position in LABU in Q2 2023 and held it in 1 quarter. The position peaked at $59.9K in Q2 2023. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Meridian Wealth Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Meridian Wealth Management sold 506 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $59.9K.
  • Meridian Wealth Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2023 and held it in 1 quarter.
  • Meridian Wealth Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $59.9K in Q2 2023.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Meridian Wealth Management's 13F filing for Q3 2023, filed 17 Oct 2023.